Literature DB >> 10405077

Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey.

R C Kessler1, P Stang, H U Wittchen, M Stein, E E Walters.   

Abstract

BACKGROUND: General population data were used to study co-morbidities between lifetime social phobia and mood disorders.
METHODS: Data come from the US National Comorbidity Survey (NCS).
RESULTS: Strong associations exist between lifetime social phobia and major depressive disorder (odds ratio 2.9), dysthymia (2.7) and bipolar disorder (5.9). Odds ratios increase in magnitude with number of social fears. Reported age of onset is earlier for social phobia than mood disorders in the vast majority of co-morbid cases. Temporally-primary social phobia predicts subsequent onset of mood disorders, with population attributable risk proportions of 10-15%. Social phobia is also associated with severity and persistence of co-morbid mood disorders.
CONCLUSIONS: Social phobia is a commonly occurring, chronic and seriously impairing disorder that is seldom treated unless it occurs in conjunction with another co-morbid condition. The adverse consequences of social phobia include increased risk of onset, severity and course of subsequent mood disorders. Early outreach and treatment of primary social phobia might not only reduce the prevalence of this disorder itself, but also the subsequent onset of mood disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10405077     DOI: 10.1017/s0033291799008375

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  61 in total

Review 1.  Unmasking social anxiety disorder.

Authors:  M B Stein; J M Gorman
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys.

Authors:  Laura Andrade; Jorge J Caraveo-Anduaga; Patricia Berglund; Rob V Bijl; Ron De Graaf; Wilma Vollebergh; Eva Dragomirecka; Robert Kohn; Martin Keller; Ronald C Kessler; Norito Kawakami; Cengiz Kiliç; David Offord; T Bedirhan Ustun; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

3.  Temporal patterns of anxious and depressed mood in generalized anxiety disorder: a daily diary study.

Authors:  Lisa R Starr; Joanne Davila
Journal:  Behav Res Ther       Date:  2011-12-07

4.  The multiple dimensions of the social anxiety spectrum in mood disorders.

Authors:  Jay C Fournier; Jill M Cyranowski; Paola Rucci; Giovanni B Cassano; Ellen Frank
Journal:  J Psychiatr Res       Date:  2012-07-05       Impact factor: 4.791

5.  Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials.

Authors:  Gabriela Bezerra de Menezes; Evandro Silva Freire Coutinho; Leonardo F Fontenelle; Paula Vigne; Ivan Figueira; Márcio Versiani
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

6.  Social anxiety and interpersonal stress generation: the moderating role of interpersonal distress.

Authors:  David M Siegel; Taylor A Burke; Jessica L Hamilton; Marilyn L Piccirillo; Adela Scharff; Lauren B Alloy
Journal:  Anxiety Stress Coping       Date:  2018-06-01

Review 7.  Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V.

Authors:  Katja Beesdo; Susanne Knappe; Daniel S Pine
Journal:  Psychiatr Clin North Am       Date:  2009-09

8.  Altered emotion regulation capacity in social phobia as a function of comorbidity.

Authors:  Lisa J Burklund; Michelle G Craske; Shelley E Taylor; Matthew D Lieberman
Journal:  Soc Cogn Affect Neurosci       Date:  2014-05-08       Impact factor: 3.436

9.  Common and distinct neural features of social and non-social reward processing in autism and social anxiety disorder.

Authors:  John A Richey; Alison Rittenberg; Lauren Hughes; Cara R Damiano; Antoinette Sabatino; Stephanie Miller; Eleanor Hanna; James W Bodfish; Gabriel S Dichter
Journal:  Soc Cogn Affect Neurosci       Date:  2012-12-07       Impact factor: 3.436

10.  Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

Authors:  Murray B Stein; Mark H Pollack; Alexander Bystritsky; Jeffrey E Kelsey; Richard M Mangano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.